Matches in SemOpenAlex for { <https://semopenalex.org/work/W2345619005> ?p ?o ?g. }
- W2345619005 endingPage "516" @default.
- W2345619005 startingPage "507" @default.
- W2345619005 abstract "Background Drug-induced agranulocytosis is a potentially life-threatening adverse reaction. Genome-wide association studies (GWASs) in ethnic Chinese people in Taiwan and Hong Kong have shown an association between agranulocytosis induced by antithyroid drugs and the HLA alleles HLA-B*38:02 and HLA-DRB1*08:03. We aimed to identify genetic variants associated with antithyroid drug-induced agranulocytosis in a white European population. Methods We did a GWAS in 234 European adults with any non-chemotherapy drug-induced agranulocytosis (absolute neutrophil count ≤0·5 × 109/L [≤500/μL]) and 5170 population controls. 39 of the 234 patients had agranulocytosis that was induced by antithyroid drugs (thiamazole [methimazole], carbimazole, or propylthiouracil). After imputation and HLA allele prediction, 9 380 034 single nucleotide polymorphisms (SNPs) and 180 HLA alleles were tested for association. The genome-wide significance threshold was p<5 × 10−8. Findings Agranulocytosis induced by non-chemotherapy drugs in general was significantly associated with the HLA region on chromosome 6, with odds ratios (ORs) of 3·24 (95% CI 2·31–4·55, p=1·20 × 10−11) for HLA-B*27:05 and 3·57 (2·61–4·90, p=2·32 × 10−15) for the top SNP (rs114291795). Drug-specific analysis showed that the association with HLA-B*27:05 was largely driven by cases induced by antithyroid drugs. In a multiple logistic regression model, the OR for HLA-B*27:05 was 7·30 (3·81–13·96) when antithyroid drug-induced agranulocytosis was compared with population controls (p=1·91 × 10−9) and 16·91 (3·44–83·17) when compared with a small group of hyperthyroid controls (p=5·04 × 10−4). Three SNPs were strongly associated with antithyroid drug-induced agranulocytosis: rs652888 (OR 4·73, 95% CI 3·00–7·44, p=1·92 × 10−11) and rs199564443 (17·42, 7·38–41·12, p=7·04 × 10−11), which were independent of HLA-B*27:05, and rs1071816 (5·27, 3·06–9·10, p=2·35 × 10−9) which was in moderate linkage disequilibrium with HLA-B*27:05. In heterozygous carriers of all three SNPs, the predicted probability of antithyroid drug-induced agranulocytosis was about 30% (OR 753, 95% CI 105–6812). To avoid one case of agranulocytosis, based on the possible risk reduction if all three SNPs are genotyped and carriers are treated or monitored differently from non-carriers, roughly 238 patients would need to be genotyped. Interpretation In white European people, antithyroid drug-induced agranulocytosis was associated with HLA-B*27:05 and with other SNPs on chromosome 6. In the future, carriers of these variants could be placed under intensified monitoring or offered alternative treatment for hyperthyroidism. Funding Swedish Research Council, Swedish Heart and Lung Foundation, Clinical Research Support at Uppsala University, German Federal Institute for Drugs and Medical Devices, Carlos III Spanish Health Institute, European Regional Development Fund, UK National Institute for Health Research, The Selander's Foundation, Thuréus Foundation, European Commission, and Science for Life Laboratory." @default.
- W2345619005 created "2016-06-24" @default.
- W2345619005 creator A5003137589 @default.
- W2345619005 creator A5007280808 @default.
- W2345619005 creator A5007345041 @default.
- W2345619005 creator A5011209485 @default.
- W2345619005 creator A5022075588 @default.
- W2345619005 creator A5022810412 @default.
- W2345619005 creator A5025930122 @default.
- W2345619005 creator A5047914572 @default.
- W2345619005 creator A5064296895 @default.
- W2345619005 creator A5066812926 @default.
- W2345619005 creator A5069907812 @default.
- W2345619005 creator A5073880418 @default.
- W2345619005 creator A5088162585 @default.
- W2345619005 creator A5091895035 @default.
- W2345619005 date "2016-06-01" @default.
- W2345619005 modified "2023-10-16" @default.
- W2345619005 title "Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population" @default.
- W2345619005 cites W1487061142 @default.
- W2345619005 cites W1858708606 @default.
- W2345619005 cites W1896195310 @default.
- W2345619005 cites W1978116054 @default.
- W2345619005 cites W1992436001 @default.
- W2345619005 cites W2060580787 @default.
- W2345619005 cites W2064239366 @default.
- W2345619005 cites W2076721759 @default.
- W2345619005 cites W2077346610 @default.
- W2345619005 cites W2098951833 @default.
- W2345619005 cites W2103247033 @default.
- W2345619005 cites W2103392332 @default.
- W2345619005 cites W2109459078 @default.
- W2345619005 cites W2116514399 @default.
- W2345619005 cites W2121867385 @default.
- W2345619005 cites W2121891611 @default.
- W2345619005 cites W2126718294 @default.
- W2345619005 cites W2134783591 @default.
- W2345619005 cites W2139741257 @default.
- W2345619005 cites W2145374140 @default.
- W2345619005 cites W2149134901 @default.
- W2345619005 cites W2158804326 @default.
- W2345619005 cites W2180196507 @default.
- W2345619005 cites W2205037416 @default.
- W2345619005 cites W2330826514 @default.
- W2345619005 cites W2402055162 @default.
- W2345619005 cites W4243225672 @default.
- W2345619005 cites W54192091 @default.
- W2345619005 cites W931662247 @default.
- W2345619005 doi "https://doi.org/10.1016/s2213-8587(16)00113-3" @default.
- W2345619005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27157822" @default.
- W2345619005 hasPublicationYear "2016" @default.
- W2345619005 type Work @default.
- W2345619005 sameAs 2345619005 @default.
- W2345619005 citedByCount "69" @default.
- W2345619005 countsByYear W23456190052016 @default.
- W2345619005 countsByYear W23456190052017 @default.
- W2345619005 countsByYear W23456190052018 @default.
- W2345619005 countsByYear W23456190052019 @default.
- W2345619005 countsByYear W23456190052020 @default.
- W2345619005 countsByYear W23456190052021 @default.
- W2345619005 countsByYear W23456190052022 @default.
- W2345619005 countsByYear W23456190052023 @default.
- W2345619005 crossrefType "journal-article" @default.
- W2345619005 hasAuthorship W2345619005A5003137589 @default.
- W2345619005 hasAuthorship W2345619005A5007280808 @default.
- W2345619005 hasAuthorship W2345619005A5007345041 @default.
- W2345619005 hasAuthorship W2345619005A5011209485 @default.
- W2345619005 hasAuthorship W2345619005A5022075588 @default.
- W2345619005 hasAuthorship W2345619005A5022810412 @default.
- W2345619005 hasAuthorship W2345619005A5025930122 @default.
- W2345619005 hasAuthorship W2345619005A5047914572 @default.
- W2345619005 hasAuthorship W2345619005A5064296895 @default.
- W2345619005 hasAuthorship W2345619005A5066812926 @default.
- W2345619005 hasAuthorship W2345619005A5069907812 @default.
- W2345619005 hasAuthorship W2345619005A5073880418 @default.
- W2345619005 hasAuthorship W2345619005A5088162585 @default.
- W2345619005 hasAuthorship W2345619005A5091895035 @default.
- W2345619005 hasBestOaLocation W23456190052 @default.
- W2345619005 hasConcept C104317684 @default.
- W2345619005 hasConcept C106208931 @default.
- W2345619005 hasConcept C126322002 @default.
- W2345619005 hasConcept C135763542 @default.
- W2345619005 hasConcept C153209595 @default.
- W2345619005 hasConcept C156957248 @default.
- W2345619005 hasConcept C203014093 @default.
- W2345619005 hasConcept C2775960720 @default.
- W2345619005 hasConcept C2776606491 @default.
- W2345619005 hasConcept C2776652619 @default.
- W2345619005 hasConcept C2779134260 @default.
- W2345619005 hasConcept C2779442721 @default.
- W2345619005 hasConcept C2908647359 @default.
- W2345619005 hasConcept C526584372 @default.
- W2345619005 hasConcept C54355233 @default.
- W2345619005 hasConcept C71924100 @default.
- W2345619005 hasConcept C86803240 @default.
- W2345619005 hasConcept C99454951 @default.
- W2345619005 hasConceptScore W2345619005C104317684 @default.
- W2345619005 hasConceptScore W2345619005C106208931 @default.